Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Claire B. Fluharty is active.

Publication


Featured researches published by Claire B. Fluharty.


The New England Journal of Medicine | 1991

Molecular basis of different forms of metachromatic leukodystrophy

Andreas Polten; Arvan L. Fluharty; Claire B. Fluharty; Joachim Kappler; Kurt von Figura; Volkmar Gieselmann

BACKGROUND Metachromatic leukodystrophy is an autosomal recessive inherited lysosomal storage disorder caused by a deficiency of arylsulfatase A. Three forms of the disease can be distinguished according to severity and the age at onset: late infantile (1 to 2 years), juvenile (3 to 16), and adult (greater than 16). METHODS AND RESULTS To understand the molecular basis of the different forms of the disease, we analyzed arylsulfatase A alleles associated with metachromatic leukodystrophy. Two alleles (termed I and A) were identified and accounted for about half of all arylsulfatase A alleles among 68 patients with metachromatic leukodystrophy whom we examined. Sufficient information was available for 66 of the patients to allow classification of their disease. Of the six instances of homozygosity for allele I, all were associated with the late-infantile form of the disease; of the eight instances of homozygosity for allele A, five were associated with the adult form and three with the juvenile form. When both alleles were present, the juvenile form resulted (seven of seven instances). Heterozygosity for allele I (with the other allele unknown) is usually associated with late-infantile disease, and heterozygosity for allele A with a later onset of the disease. The clinical variability can be explained by the different levels of residual arylsulfatase A activity associated with these genotypes. CONCLUSIONS Like many lysosomal storage disorders, metachromatic leukodystrophy shows clinical heterogeneity that seems to reflect genetic heterogeneity. One of the known alleles (allele I) is associated with earlier and more severe disease than the other (allele A).


Journal of Neuroscience Research | 2001

Comparative lipid binding study on the cerebroside sulfate activator (saposin B)

Claire B. Fluharty; Jeffery Johnson; Julian P. Whitelegge; Kym F. Faull; Arvan L. Fluharty

Cerebroside sulfate activator (saposin B) is a small protein involved in glycosphingolipid metabolism. It binds certain membrane lipids, making them available to water‐soluble enzymes. Defects in this protein are responsible for a form of metachromatic leukodystropy, a progressive neurodegenerative condition. The protein participates in the catabolism of a number of lipids but does show lipid binding selectivity. However, the basis of this selectivity is unclear. Here we assess the relative binding of a number of lipids compared to cerebroside sulfate (sulfatide). We utilize a competitive binding paradigm, in which the lipids compete for protein under favorable conditions and are then switched to a condition in which the complex is stable. This study is unique in that a single molecular species of the activator is employed, and an expanded selection of natural and semisynthetic membrane lipids is surveyed. No simple “binding rule” can be ascertained from these data, but ligands with longer and/or more complex lipoidal and polar adducts appear to be favored. J. Neurosci. Res. 63:82–89, 2001.


Journal of Mass Spectrometry | 1999

Cerebroside sulfate activator protein (Saposin B): chromatographic and electrospray mass spectrometric properties.

Kym F. Faull; Julian P. Whitelegge; Jason Higginson; Trang To; Jeffrey Johnson; Andrew N. Krutchinsky; Kenneth G. Standing; Alan J. Waring; Richard L. Stevens; Claire B. Fluharty; Arvan L. Fluharty

Cerebroside sulfate activator protein is a small, heat-stable protein that is exceptionally resistant to proteolytic attack. This protein is essential for the catabolism of cerebroside sulfate and several other glycosphingolipids. Protein purified from pig kidney and human urine was extensively characterized by reversed-phase liquid chromatography and electrospray mass spectrometry. These two sources revealed 20 and 18 different molecular isoforms of the protein, respectively. Plausible explanations of the structures of the majority of these isoforms can be made on the basis of accurate molecular mass assignments. The reversed-phase chromatographic and electrospray mass spectrometric properties of enzymatically deglycosylated and disulfide-reduced protein were also compared. In addition to a demonstration of the power of electrospray ionization mass spectrometry for revealing a wealth of information on protein microheterogeneity and structural detail, the results also demonstrate the utility of this technique for monitoring spontaneous chemical and enzymatically mediated changes that occur as a result of metabolic processing and protein purification.


Journal of Mass Spectrometry | 2000

Structure of the asparagine-linked sugar chains of porcine kidney and human urine cerebroside sulfate activator protein

Kym F. Faull; Jeffrey Johnson; Moon Jae Kim; Trang To; Julian P. Whitelegge; Richard L. Stevens; Claire B. Fluharty; Arvan L. Fluharty

The specific sugar residues and their linkages in the oligosaccharides from pig kidney and human urine cerebroside sulfate activator proteins (saposin B), although previously hypothesized, have been unambiguously characterized. Exhaustive sequential exoglycosidase digestion of the trimethyl-p-aminophenyl derivatives, followed by either matrix-assisted laser desorption/ionization and/or mass spectrometry, was used to define the residues and their linkages. The oligosaccharides were enzymatically released from the proteins by treatment with peptidyl-N-glycosidase F and separated from the proteins by reversed-phase high-performance liquid chromatography (HPLC). Reducing termini were converted to the trimethyl-p-aminophenyl derivative and the samples were further purified by normal-phase HPLC. The derivatized carbohydrates were then treated sequentially with a series of exoglycosidases of defined specificity, and the products of each digestion were examined by mass spectrometry. The pentasaccharides from pig kidney and human urine protein were shown to be of the asparagine-linked complex type composed of mannose-alpha 1-6-mannose-beta 1-4-N-acetylglucosamine-N-acetylglucosamine(alpha 1-6-fucose). This highly degraded structure probably represents the final product of intra-lysosomal exoglycosidase digestion. Oligosaccharide sequencing by specific exoglycosidase degradation coupled with mass spectrometry is more rapid than conventional oligosaccharide sequencing. The procedures developed will be useful for sequencing other oligosaccharides including those from other members of the lipid-binding protein class to which cerebroside sulfate activator belongs. (c) 2000 John Wiley & Sons, Ltd.


Journal of Mass Spectrometry | 2000

Hydrogen-deuterium exchange signature of porcine cerebroside sulfate activator protein.

Kym F. Faull; Jason Higginson; Alan J. Waring; Trang To; Julian P. Whitelegge; Richard L. Stevens; Claire B. Fluharty; Arvan L. Fluharty

Hydrogen-deuterium exchange can be a sensitive indicator of protein structural integrity. Comparisons were made between cerebroside sulfate activator protein (CSAct) in the native state and after treatment with guanidine hydrochloride plus dithiothreitol. Native protein has three internal disulfide bonds and treated protein has no internal disulfide bonds. The comparisons were made using hydrogen-deuterium exchange measured by electrospray ionization mass spectrometry, percentage alpha-helical content measured by circular dichroism and biological activity measured by the ability to support arylsulfatase A-catalyzed sulfate hydrolysis from cerebroside sulfate. In acidic solvent native protein has 59 exchange refractory protons and treated protein has 20 exchange refractory protons (44 and 14% of the exchangeable proton populations, respectively). In native protein the size of the exchange refractory proton population is sensitive to changes in pH, temperature and the presence of a ligand. It is uninfluenced by the presence or absence of glycosyl groups attached to Asn21. Helical content is virtually identical in native and treated protein. Biological activity is significantly reduced but not obliterated in treated protein. The hydrogen-deuterium exchange profile appears to be a sensitive signature of the correctly folded protein, and reflects a dimension of the protein structure that is not apparent in circular dichroic spectra or in the ability of the protein to support arylsulfatase A-catalyzed sulfate hydrolysis from sulfatide. The hydrogen-deuterium exchange profile will be a valuable criterion for characterizing mutant forms of CSAct produced by recombinant and synthetic paradigms and also the native and mutant forms of related proteins.


American Journal of Human Genetics | 1991

Two new arylsulfatase A (ARSA) mutations in a juvenile metachromatic leukodystrophy (MLD) patient.

Arvan L. Fluharty; Claire B. Fluharty; Wolfgang Bohne; K von Figura; Volkmar Gieselmann


Protein Science | 2000

Methionine oxidation within the cerebroside-sulfate activator protein (CSAct or Saposin B).

Julian P. Whitelegge; Brandon Penn; Trang To; Jeffrey Johnson; Alan J. Waring; Mark A. Sherman; Richard L. Stevens; Claire B. Fluharty; Kym F. Faull; Arvan L. Fluharty


Archives of Biochemistry and Biophysics | 2000

Disulfide Connectivity in Cerebroside Sulfate Activator Is Not Necessary for Biological Activity or α-Helical Content but Is Necessary for Trypsin Resistance and Strong Ligand Binding

Kym F. Faull; Jason Higginson; Alan J. Waring; Jeffrey Johnson; Trang To; Julian P. Whitelegge; Richard L. Stevens; Claire B. Fluharty; Arvan L. Fluharty


Journal of Lipid Research | 2005

A novel mass spectrometric assay for the cerebroside sulfate activator protein (saposin B) and arylsulfatase A

Andrew J. Norris; Julian P. Whitelegge; Arman Yaghoubian; Jean-René Alattia; Gilbert G. Privé; Tatsushi Toyokuni; Hubert Sun; Mai N. Brooks; Luigi Panza; Pamela Matto; Federica Compostella; Natascha Remmel; Ralf Klingenstein; Konrad Sandhoff; Claire B. Fluharty; Arvan L. Fluharty; Kym F. Faull


Cellular and Molecular Biology | 2003

Characterization of A recombinant molecule covalently indistinguishable from human cerebroside-sulfate activator protein (CSAct or saposin B)

Julian P. Whitelegge; Ahn; Andrew J. Norris; Sung H; Alan J. Waring; Richard L. Stevens; Claire B. Fluharty; Gilbert G. Privé; Kym F. Faull; Arvan L. Fluharty

Collaboration


Dive into the Claire B. Fluharty's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kym F. Faull

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alan J. Waring

Los Angeles Biomedical Research Institute

View shared research outputs
Top Co-Authors

Avatar

Trang To

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge